Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |